Annual Operating Profit
-$139.03 M
-$9.50 M-7.33%
31 December 2023
Summary:
C4 Therapeutics annual operaing income is currently -$139.03 million, with the most recent change of -$9.50 million (-7.33%) on 31 December 2023. During the last 3 years, it has fallen by -$78.58 million (-130.00%). CCCC annual operating profit is now -748.32% below its all-time high of -$16.39 million, reached on 31 December 2018.CCCC Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$28.24 M
-$6.80 M-31.72%
30 September 2024
Summary:
C4 Therapeutics quarterly operating income is currently -$28.24 million, with the most recent change of -$6.80 million (-31.72%) on 30 September 2024. Over the past year, it has dropped by -$436.00 thousand (-1.57%). CCCC quarterly operating profit is now -182.41% below its all-time high of -$10.00 million, reached on 30 September 2019.CCCC Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$116.89 M
-$436.00 K-0.37%
30 September 2024
Summary:
C4 Therapeutics TTM operating income is currently -$116.89 million, with the most recent change of -$436.00 thousand (-0.37%) on 30 September 2024. Over the past year, it has increased by +$23.00 million (+16.44%). CCCC TTM operating profit is now -1068.83% below its all-time high of -$10.00 million, reached on 30 September 2019.CCCC TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CCCC Operating Profit Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -7.3% | -1.6% | +16.4% |
3 y3 years | -130.0% | -16.4% | -36.3% |
5 y5 years | -748.3% | -182.4% | -1068.8% |
CCCC Operating Profit High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -130.0% | at low | -85.2% | +26.2% | -42.3% | +19.1% |
5 y | 5 years | -748.3% | at low | -182.4% | +26.2% | -1068.8% | +19.1% |
alltime | all time | -748.3% | at low | -182.4% | +26.2% | -1068.8% | +19.1% |
C4 Therapeutics Operating Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$28.24 M(+31.7%) | -$116.89 M(+0.4%) |
June 2024 | - | -$21.44 M(-28.0%) | -$116.46 M(-12.2%) |
Mar 2024 | - | -$29.78 M(-20.4%) | -$132.59 M(-4.6%) |
Dec 2023 | -$139.03 M(+7.3%) | -$37.43 M(+34.6%) | -$139.03 M(-0.6%) |
Sept 2023 | - | -$27.81 M(-26.0%) | -$139.90 M(-3.2%) |
June 2023 | - | -$37.57 M(+3.7%) | -$144.58 M(+7.6%) |
Mar 2023 | - | -$36.23 M(-5.4%) | -$134.39 M(+3.8%) |
Dec 2022 | -$129.53 M(+57.7%) | -$38.29 M(+17.9%) | -$129.53 M(+21.6%) |
Sept 2022 | - | -$32.49 M(+18.6%) | -$106.50 M(+8.4%) |
June 2022 | - | -$27.38 M(-12.7%) | -$98.26 M(+5.7%) |
Mar 2022 | - | -$31.37 M(+105.6%) | -$92.99 M(+13.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | -$82.13 M(+35.9%) | -$15.26 M(-37.1%) | -$82.13 M(-4.3%) |
Sept 2021 | - | -$24.25 M(+9.7%) | -$85.78 M(+7.4%) |
June 2021 | - | -$22.12 M(+7.8%) | -$79.88 M(+16.4%) |
Mar 2021 | - | -$20.51 M(+8.5%) | -$68.62 M(+13.5%) |
Dec 2020 | -$60.45 M(+70.5%) | -$18.90 M(+3.0%) | -$60.45 M(+16.1%) |
Sept 2020 | - | -$18.35 M(+69.0%) | -$52.05 M(+19.1%) |
June 2020 | - | -$10.86 M(-12.0%) | -$43.70 M(+33.1%) |
Mar 2020 | - | -$12.34 M(+17.5%) | -$32.84 M(+60.2%) |
Dec 2019 | -$35.45 M(+116.3%) | -$10.50 M(+5.0%) | -$20.50 M(+105.0%) |
Sept 2019 | - | -$10.00 M | -$10.00 M |
Dec 2018 | -$16.39 M | - | - |
FAQ
- What is C4 Therapeutics annual operaing income?
- What is the all time high annual operating profit for C4 Therapeutics?
- What is C4 Therapeutics annual operating profit year-on-year change?
- What is C4 Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for C4 Therapeutics?
- What is C4 Therapeutics quarterly operating profit year-on-year change?
- What is C4 Therapeutics TTM operating income?
- What is the all time high TTM operating profit for C4 Therapeutics?
- What is C4 Therapeutics TTM operating profit year-on-year change?
What is C4 Therapeutics annual operaing income?
The current annual operating profit of CCCC is -$139.03 M
What is the all time high annual operating profit for C4 Therapeutics?
C4 Therapeutics all-time high annual operaing income is -$16.39 M
What is C4 Therapeutics annual operating profit year-on-year change?
Over the past year, CCCC annual operaing income has changed by -$9.50 M (-7.33%)
What is C4 Therapeutics quarterly operating income?
The current quarterly operating profit of CCCC is -$28.24 M
What is the all time high quarterly operating profit for C4 Therapeutics?
C4 Therapeutics all-time high quarterly operating income is -$10.00 M
What is C4 Therapeutics quarterly operating profit year-on-year change?
Over the past year, CCCC quarterly operating income has changed by -$436.00 K (-1.57%)
What is C4 Therapeutics TTM operating income?
The current TTM operating profit of CCCC is -$116.89 M
What is the all time high TTM operating profit for C4 Therapeutics?
C4 Therapeutics all-time high TTM operating income is -$10.00 M
What is C4 Therapeutics TTM operating profit year-on-year change?
Over the past year, CCCC TTM operating income has changed by +$23.00 M (+16.44%)